A major discovery in cancer investigation is occurring with the use of nanobodies to reactivate dysfunctional p53. This essential cancer inhibitor protein is frequently disabled in various kinds of malignancies, https://www.zenhealths.com/p53-reactivation-nanobody-cancer-research